Phase 1 Stage IV Non-Small Cell Lung Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Metastatic MelanomaUnresectable MelanomaStage IV Non-Small Cell Lung Cancer+1 more

Iovance Biotherapeutics, Inc.53 enrolled11 locationsNCT05361174

Recruiting

Phase 1

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Non-small Cell Lung CancerStage IV Non-Small Cell Lung CancerRecurrent Non-small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute20 enrolled1 locationNCT05681780